Helius Medical Technologies Inc, based in Newtown, Pennsylvania, specializes in non-implantable neurotech devices like PoNS, which treats neurologic diseases by stimulating the tongue to improve gait and balance deficits. The company, which went public in 2014, focuses on developing technologies to alleviate symptoms of neurological disorders.
Helius Medical Technologies (HSDT) reported a negative EPS surprise in its most recent quarterly earnings. For the most recent quarter, Helius Medical Technologies's actual EPS was -$0.64, missing the estimate of -$0.51 per share, resulting in a -25.49% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
